Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Effects of Varied Rehabilitation Techniques on Survivors of Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
A randomized controlled blinded study in patients treated for Acute Respiratory Distress Syndrome (ARDS) in the mixed medical-surgical intensive care units (ICU) of four academic teaching hospitals in Tehran, Iran were conducted to examine the effects of Varied Rehabilitation Techniques on Survivors of ARDS patients. Patients were randomized in the emergency department at the time of ICU admission to one of four groups labeled groups 1, 2, 3 and 4, respectively.
The intervention package had three phases including pre-intervention, intervention, and
post-intervention phases. Pre-intervention: During the pre-intervention phase, patients
completed the quality-of-life assessment (SF-36), perceived stress questionnaire (PSQ-14),
and State and Trait Anxiety, Barthel Index (BI) and Kessler Psychological Distress Scale
(K10) questionnaires as well as a Six-minute walk test (6MWT), and 51 times walking per 5
years (at discharge, month 1 to month 42 (each month), and months 45, 48, 51, 54, 57, 60,
63, and 66). A rehabilitation plan was formulated incorporating considerations for the
patient's identified strengths' and weaknesses. See the RP section.
Intervention: Once discharged, patients called their study nurse every 2 days to report any
problems or complications. Patients were evaluated by their primary multidisciplinary
medical team including their pulmonologist, intensivist, internist, psychologist,
psychiatrist, physical therapist, and occupational therapist on a weekly basis and at 30
days. At each visit, the patient was interviewed, underwent a physical examination,
pulmonary-function testing (PFT), posterior-anterior and lateral (PA-Lat) chest radiography
(CXR), resting oximetry, a standardized 6MWT with continuous oximetry, free walking test as
long as the stamina and capability of patient, and laboratory tests as indicated. At other
times, if patients experienced a problem or complication, they notified investigators and
presented to either their multidisciplinary medical team or their primary care provider for
evaluation. Patients in the group 1 received rehabilitation employing the mixed model:
Family-Centered Empowerment Model (FCEM) and Continuous Care Model (CCM). Group 2 received
rehabilitation employing the FCEM, and Group 3 employed CCM, each in 4 stages. Stage 1 of
the intervention was awareness and cognition. The patient was evaluated for their insight
into their perceived illness severity and perceived sensitivity, or the degree to which they
felt threatened by their illness. This was performed by means of 3-5 group sessions in the
pre-intervention phase. Group sessions included 3-5 patients and lasted for 45-60 min each.
Session content included assessments of the participants' psychological and physical
conditions as well as their attitude towards the nature, definition, risk factors, symptoms,
medical and nursing care, and complications resulting from the ARDS. In stage 2, patients
were assessed for their expectations over 3-5 one-hour sessions. Groups of 3-4 patients
shared and learnt from each other under the moderation and guidance of the principal
researcher. In stage 3, the degree of patient acceptance was assessed using an educational
participation method in group discussion. Patients reached practical solutions through using
the problem-solving findings of the previous stage. Stage 4 consisted of formative and
summative evaluations. The aim of the formative evaluation was to encourage patients to
internalize their locus of control by encouraging personal responsibility about issues of
health and seeing his/her self-empowerment. Summative evaluations were performed to evaluate
the influence of the intervention on the study's medical outcomes. The study's medical
outcomes were assessed in pre intervention, measurement 2 (10-day post intervention),
measurement 3 (three-month post measurement 2), and ten following ups includes six
three-month periods (6, 9, 12, 15, 18, 21), four six-month periods (27, 33, 39, 45), and two
twelve-month period (57, and 69) after intervention by deploying FCEM and CCM
questionnaires.
Post-intervention follow-up: Phase 3 began 90 days following pre-intervention (control
group), and 90 days after measurement 3 in three intervention groups. To assess the
durability and stability of patient empowerment, patient knowledge, attitude and practice
(KAP) was assessed over ten follow-up sessions with mentioned intervals. During the 66-month
follow-up period, patients attended a total of 56 support-group webinars addressing topics
including returning to work, intimate relationships, nutrition, sleep hygiene, tobacco use,
exercise, and leisure activities as well as testing and laboratory issues. Follow-up
interviews were conducted during home visits, when available, or with the assistance of
telephone, Skype, Viber or WhatsApp according to patient preference.
Role of the Designee: Following informed consent, the designated family member or friend
(hereafter called designee) continued through the study with the patient as a 'unit'. The
designee attended the patient's educational sessions during stages 3 and 4, with stage 2
being according to the family member preference. Recall that stage 2 deals with patient
expectations, stage 3 with patient acceptance and problem-solving, and stage 4 with
evaluations and internalizing his/her locus of control. The designee and the patient
attended the same sessions, and studied the same learning materials. Up to eight family
members were allowed to join in the educational sessions if requested. In stage 3, the
designee was charged with learning and reinforcing educational material with the patient. In
stage 4, when instructed by study investigators, the designee would administer the KAP
assessments to the patient. In addition to scores, the designee would provide additional
information on the patient's home situation and current condition. Patients were assigned a
code, and de-identified data were transmitted from the designee to investigators either by
encrypted email, telephone, mail or in person.
Rehabilitation plan: All patients had similar inpatient rehabilitation programs. For
patients in the three intervention groups, outpatient rehab included daily exercise for 0-2
h/day. Exercise occurred between 8:00 and 10:00, and types included walking, jogging,
bicycle, swimming, or other exercise according to patient preference or resource
availability and confirmed by multidisciplinary medical team. Daily exercise was supervised
by designated family members. Investigators randomly attended sessions in an unannounced
fashion. Although not routinely involved, multidisciplinary medical team consultations were
available on investigator request. Exercise data were independently collected from the
patient and their designated family member on a weekly basis (κ statistic=0.94). To measure
the patients' walking distance, investigators provided them with a Fit bit (Fit bit, San
Francisco, USA). Routine care included education on smoking cessation and education on food
selection. Patients were provided printed materials, with dietician assessments available on
request. Patients in the control group received the same education and printed materials
during their inpatient course. Patients exercised daily, at any time, for ≤2 h according to
patient tolerance. Sessions were supervised by family members. Investigators did not attend
sessions. Exercise data were independently collected from the patient and their designated
family member on a weekly basis (κ statistic=0.22). Again, walking distance was measured
using the Fit bit. Routine care included education on smoking cessation and education on
food selection. Patients were provided printed materials, with dietician assessments
available on request.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |